The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. (Q36441711)

14 August 2017

1 reference

title

The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. (English)

1 reference

14 August 2017

0 references

1 reference

Bram van Kooij

1

1 reference

14 August 2017

Aniki Rothova

series ordinal

2

1 reference

14 August 2017

Philip de Vries

series ordinal

3

1 reference

14 August 2017

language of work or name

1 reference

1 April 2006

1 reference

Ocular Immunology and Inflammation

14 August 2017

1 reference

14 August 2017

14

1 reference

14 August 2017

2

1 reference

14 August 2017

73-85

1 reference

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

14 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Serum levels of triamcinolone acetonide after intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

The possible impact of uveitis in blindness: a literature survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Causes and frequency of blindness in patients with intraocular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Degree, duration, and causes of visual loss in uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide in sympathetic ophthalmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intraocular availability of triamcinolone acetonide after intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Risks of intravitreous injection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Noninfectious endophthalmitis associated with intravitreal triamcinolone injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Acute endophthalmitis following intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Minimizing the risk of endophthalmitis following intravitreous injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Evolving guidelines for intravitreous injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone acetonide and intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intraocular pressure after intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Safety of intravitreal high-dose reinjections of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Cataract surgery after intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940500545684

10.1080/09273940500545684

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference